Clinical Trials Sponsored by National Cancer Institute, Naples

Total 22066 results

National Cancer Institute (NCI)

Completed

A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin

Thyroid Neoplasm

United States
National Cancer Institute (NCI)

Terminated

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemias | Multiple Myeloma With Plasmacytoma

United States
National Cancer Institute (NCI)

Completed

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Neurofibromatosis 1 | Neurofibroma, Plexiform

United States
National Cancer Institute (NCI)

Completed

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Completed

Montelukast to Treat Bronchiolitis Obliterans

Chronic Graft Versus Host Disease | Stem Cell Transplant | Bronchiolitis Obliterans | Leukotriene | Montelukast

United States
National Cancer Institute (NCI)

Completed

Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients

Multiple Endocrine Neoplasia Type 2 | Medullary Thyroid Carcinoma

United States
National Cancer Institute (NCI)

Completed

Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta

Cervical Intraepithelial Neoplasia

United States
National Cancer Institute (NCI)

Completed

Self-Affirmation, Emotion, and Alcohol Consumption

Risk Reduction Behavior

United States
National Cancer Institute (NCI)

Completed

Genetic Analysis of Psoriasis and Psoriatic Arthritis

Psoriasis

United States
National Cancer Institute (NCI)

Completed

Breath Test for Chemicals (Volatile Organic Compounds)

Human Volunteers | Pilot Study | Breath Tests

United States
National Cancer Institute (NCI)

Terminated

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Collection of Transplant Stem Cells for Plasma Cell Myeloma

Multiple Myeloma | Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Terminated

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

Sarcoma | Ewing Sarcoma

United States
National Cancer Institute (NCI)

Completed

Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma

Lymphoma

United States
National Cancer Institute (NCI)

Completed

Cancer Vaccine Targeting Brachyury Protein in Tumors

Neoplasms | Adenocarcinoma | Colon Neoplasms | Malignant Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Leukemia | Chronic | Lymphocytic

United States
National Cancer Institute (NCI)

Completed

F-18 Sodium Fluoride in Prostate Cancer

Prostate Neoplasm

United States
National Cancer Institute (NCI)

Completed

Sequential Vaccinations in Prostate Cancer Patients

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group

Sarcoma | Leukemia | Pediatric Cancer | Brain Tumors

United States
National Cancer Institute (NCI)

Completed

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

HIV Infections | Kaposi's Sarcoma | HIV Seronegativity

United States
National Cancer Institute (NCI)

Completed

PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy

Cancer

United States
National Cancer Institute (NCI)

Completed

Imaging in MGUS, SMM and MM

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
National Cancer Institute (NCI)

Terminated

A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Thymic Carcinoma | Thymoma

United States
National Cancer Institute (NCI)

Terminated

Drosophila-generated CTL

Metastatic Cutaneous Melanoma

United States
National Cancer Institute (NCI)

Terminated

Vaccine Treatment of Kidney Cancer

Kidney Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases

Peritoneal Carcinomatosis | Colorectal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Informed Consent in Pediatric Cancer Trials

Leukemia | Osteosarcoma | Neuroblastoma | Brain Tumors | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis

Invasive Pulmonary Aspergillosis | Immunocompromised Host | Invasive Pulmonary Fungal Infection | Invasive Pulmonary Zygomycosis

United States
National Cancer Institute (NCI)

Completed

Amplification of Merkel Cell Polyomavirus From Skin Swabs

Polyomavirus

United States
National Cancer Institute (NCI)

Completed

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Cryptococcosis

United States
National Cancer Institute (NCI)

Completed

Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

SNX-5422 to Treat Solid Tumor Cancers and Lymphomas

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

Liver Neoplasms

United States
National Cancer Institute (NCI)

Withdrawn

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Sarcoma | Osteosarcoma | Brain Tumor | Neuroblastoma | Wilms Tumor

United States
National Cancer Institute (NCI)

Completed

Tabectedin to Treat Children and Adolescents With Cancer

Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

Solid Tumors | Lymphomas

United States
National Cancer Institute (NCI)

Completed

Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium

End Stage Renal Disease (ESRD)

United States
National Cancer Institute (NCI)

Completed

Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer

Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis

End Stage Renal Disease | ESRD

United States
National Cancer Institute (NCI)

Completed

PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer

Prostate Cancer | Prostate Neoplasm

United States
National Cancer Institute (NCI)

Completed

HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers

HIV Infections | Lung Cancer | Drug Addiction | AIDS | Tobacco Addiction

United States
National Cancer Institute (NCI)

Completed

CDDO to Treat Solid Tumors and Lymphomas

Lymphoma | Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica

HTLV-I

Jamaica
National Cancer Institute (NCI)

Completed

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Myelodysplastic Syndrome (MDS) | Non-Hodgkin's Lymphoma (NHL) | Leukemia, Acute Myelogenous (AML) | Leukemia, Acute Lymphocytic (ALL) | Leukemia, Chronic Myelogenous (CML)

United States
National Cancer Institute (NCI)

Completed

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

Hereditary Leiomyomatosis and Renal Cell Cancer | Cutaneous Leiomyomas

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors

Lung Cancer | Prostate Cancer | Bladder Cancer | Thymic Cancer

United States
National Cancer Institute (NCI)

Terminated

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Breast Cancer | Bladder Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Terminated

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Multiple Myeloma | Leukemia, Plasma Cell

United States
National Cancer Institute (NCI)

Completed

ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

Colorectal Neoplasms | Colorectal Tumors | Colorectal Carcinoma

United States

Clinical Trials Sponsored by National Cancer Institute, Naples

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations